We Can’t Wait to See You at
AUA2024 Booth 311
Device Tech Talk Stage in the Science & Technology Hall — Booth #1733
The iTind™ Procedure: Reshaping BPH Treatment
Friday, May 3rd | 11:00 AM - 11:25 AM
Hear from experts on this novel BPH procedure; how it was invented, how it works and who are ideal patients for treatment. See more about reshaping BPH before the show!
Device Tech Talk Stage in the Science & Technology Hall — Booth #1733
SOLTIVE™ SuperPulsed Thulium Fiber Laser
Saturday, May 4th | 10:30 AM – 10:50 AM
Hear from Dr. Mantu Gupta and the SOLTIVE SuperPulsed Laser System lead engineer as they highlight the versatility of this laser platform.
Dr. Gupta is a paid consultant to Olympus Corporation of the Americas
Skills Challenge — Booth #311
Skills Challenge Accepted!
Visit us at Booth #311 to participate in our skills challenge and test your technique removing renal stones. Will you be the high-scoring winner? Find out how you compare to your peers. This skills challenge is open to all physicians and residents.
We’ve balanced our offerings with experts and early adopters of our urology solutions for hospitals, ambulatory centers, and offices.
Stop by Booth #311 to learn more about the iTind procedure, stone management with the versatile, SOLTIVE SuperPulsed Laser System, and find out more about our complete portfolio of products for stone management.
Sponsor of the 2024 AUA GUIDELINES AT A GLANCE Compendium Book.
Available exclusively at the Olympus Booth #311
Implantation of the iTind™ device may cause urinary urgency, pelvic discomfort, dysuria or hematuria. In rare cases, the iTind procedure may cause a urinary tract infection or acute urinary retention.
The SOLTIVE™ SuperPulsed Laser, powered by a novel energy source, is capable of dusting stones in half the time and fragmenting stones relentlessly with virtually no retropulsion. For effective dusting and fragmentation, the tip of the laser fiber should be directly in contact with the stone. Continuous irrigation should be used to wash away stone fragments and to provide cooling of the treatment site. The use of higher power settings should be avoided, especially when the fiber tip is in close proximity to the ureteral wall, as perforation of the ureter may result. As with non-laser surgery, the possibility of complications and adverse events, such as chills, fever, edema, hemorrhage, inflammation, tissue necrosis, or infection may occur following treatment. In extreme cases, death may occur due to procedural complications, concurrent illness, or laser application. As with any conventional surgery, acute pain may occur immediately following laser therapy and may persist for as long as 48 hours. For further information please refer to the SOLTIVE™ Laser System IFU - PN0015551_AE.